Font Size: a A A
Keyword [Everolimus]
Result: 21 - 40 | Page: 2 of 4
21. A Meta-analysis Of Everolimus-eluting Stents Versus Sirolimus-eluting Stents In The Treatment Of Coronary Artery Disease
22. Safety And Efficacy Of Everolimus In De Novo Liver Transplant Recipients:a Systerm Review
23. Study Of Effects And Mechanism Of MTOR Inhibitors Everolimus On Human Prostate Cancer PC-3Cell Lines In Vitro
24. Safety And Efficacy Of Short Term Versus Long Term Dual Anti-platelet Therapy After Second Generation Drug Eluting Stent Therapy: A Meta-analysis
25. The Effects Of MTOR Inhibitors Everolimus On Neuroendocrine Tumors
26. A Clinical Trial Of Bioabsorbable Vascular Scaffold In Treatment Of Primary Native Coronary Artery Lesions
27. Metabolic-related Adverse Events With The Use Of Everolimus For Cancer Therapy:Systematic Review And Meta-analysis
28. Primary Research Of The Inhibition Of PARP Inhibitor,Salin Omycin, Everolimus And Sunitinib On Breast Cancer BT-20 Stem Cells
29. Roles And Mechanisms Of Everolimus Combined ATRA On ATRA-resistance Aute Promyelocytic Leukemia
30. Pharmacokinetics Study Of Everolimus Tablet In Healthy Volunteers
31. Synergistic Effects Of Everolimus And Paclitaxel On Cell Proliferation And Apoptosis In Drug-resistant Human Breast Cancer Cells
32. Studies On The Purification Of Natural Product Rapamycinand Synthesis Of Its Derivative Everolimus
33. Sirolimus Stents And Everolimus Stents For The Treatment Of Non St-elevation Acute Coronary Syndrome
34. Intermediate-term Clinical Outcomes Of Coronary Heart Disease Treated By Everolimus-eluting Stent Or Rapamycin-eluting Stent
35. Long-term Clinical Outcomes Of Everolimus Eluting-stents Compared To Sirolimus-Eluting Stents For The Treatment Of Coronary Heart Disease
36. Effects Of Glivec Combined With Everolimus On Mouse Pituitary Tumor Cell Line AtT-20
37. Efficacy And Safety Analysis Of Everoliums Combined Endocrine Therapy For Hormone Receptor Positive Advanced Breast Cancer
38. The Effects Of MTOR Inhibitors Evcrolimus On Neuroendocrine Tumors
39. Everolimus Exhibits Antitumor Activity In Obesity-induced Ovarian Cancer
40. Meta-Analysis Of Everolimus Eluting Stents Versus Zotarrolimus Eluting Stents For Treating The Patients With Coronary Artery Disease
  <<First  <Prev  Next>  Last>>  Jump to